Bernstein Liebhard LLP Announces Investigation of HealthSpring, Inc.

NEW YORK--(BUSINESS WIRE)--Bernstein Liebhard LLP is investigating whether the Board of Directors of HealthSpring, Inc. (“HealthSpring” or the “Company”) (NYSE:HS) breached its fiduciary duty to its shareholders in agreeing to sell HealthSpring to Cigna Corporation.